Drug
Ro5126766
Ro5126766: highest development phase Phase 1, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO5126766 NCT03681483 | Phase 1 | Advanced Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Ro5126766 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.